OCUGEN, INC. Conversion of Stock, Shares Converted
OCUGEN, INC. (OCGN) had Conversion of Stock, Shares Converted of 10.74 million shares as of 2016-09-29, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2017-03-16
- OCUGEN, INC. conversion of stock, shares converted for fiscal 2014 was 4.56M shares.
| Period end | Conversion of Stock, Shares Converted | Conversion of Stock, Shares Converted 12 month |
|---|---|---|
| 2016-09-29 | 10.74M shares 10-K · filed 2017-03-16 | |
| 2015-12-08 | 5.16M shares 10-K · filed 2016-03-10 | |
| 2014-12-31 | 4.56M shares 10-K · filed 2016-03-10 | |
| 2014-12-08 | 5.16M shares 10-Q · filed 2015-11-12 | |
| 2014-12-03 | 5.16M shares 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |